The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
CA125 as a predictive marker for optimal interval debulking surgery in advanced ovarian cancer.
N. Furukawa
No relevant relationships to disclose
H. Shigetomi
No relevant relationships to disclose
S. Yoshida
No relevant relationships to disclose
R. Kawaguchi
No relevant relationships to disclose
S. Komeda
No relevant relationships to disclose
Y. Tanase
No relevant relationships to disclose
Y. Yamada
No relevant relationships to disclose
H. Kobayashi
No relevant relationships to disclose